Sequenom, Inc.
mySequenom • Contact • Careers • 
Harry Hixson
Allan Bombard
Charles Cantor
Alisa Judge
Ronald Lindsay
Paul Maier
Shawn Marcell
Michael Monko
Larry Myres
Clarke Neumann
Gary S. Riordan
Ernst-Günter Afting
Kenneth Buechler
Charles R. Cantor
John A. Fazio
Harry F. Hixson
Richard A. Lerner
Ronald M. Lindsay
David Pendarvis
Kathleen M. Wiltsey
Allan Bombard
Frank A. Chervenak
Arnold W. Cohen
W. Allen Hogge
Wolfgang Holzgreve
Dennis Lo
Lee P. Shulman
Yves Ville
Contact Us Form
Vision & Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Locations and Contact
DNA Methylation Analysis
SNP Genotyping
Molecular Typing
Rare Mutation Profiling
Gene Expression Analysis
Cancer Solutions
Translational Research
Hardware and Options
Compact 96
Applications
Research Area
Systems
Fetal Nucleic Acid Technology
Clinical Studies
Archive
2010 Road Show
Investor Kit
Financial Reports
Fundamentals
Stock Information
SEC Filings
Corporate Governance
Analyst Coverage
Email Form
Jobs
Benefits
Development
Diversity
Activities & Services
Recruiter Message
News
Newsletters
Events
Webcasts
Investor Relations
Careers
Intellectual Property
2009 Proxy Materials
Genotyping FAQs
QGE FAQs
EpiTYPER FAQs
iPLEX Genotyping
QGE Gene Expression
EpiTYPER DNA Methylation Analysis
Overview
Grant Resources
FAQs
Training and Upcoming Events
Literature
Ordering Information
Contact Support
About UsGenetic AnalysisDiagnosticsCorporateSupport

iPLEX®Gold

Accelerate your fine mapping and validation

Rapid, flexible genotyping assays in less than a day

» Learn More...
SEQureDX

Noninvasive Prenatal Diagnostics

The Dawn of a New Technology

» Learn More...

EpiTYPER®

Quantitative DNA Methylation Analysis Simplified

Quantitation and Discovery in Regions up to 500 bp in one Reaction

» Learn More...

iSEQ™

A New Standard in Molecular Microbial Typing

Customize Your Comparative Sequence Analysis

» Learn More...
 
 
In the News
  • 2/9/2010 - Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
  • 2/4/2010 - Sequenom Announces Launch of SensiGene Fetal RHD Genotyping Test
  • 1/28/2010 - Sequenom Announces Addition to Clinical Advisory Board
  • 1/15/2010 - Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
Spotlight
  • Upcoming Events
  • Customer Seminar Showcase – "Supporting Personalized Cancer Medicine with the MassARRAY System"
  • OncoCarta™ Panel v. 1.0 – Comprehensive multi-gene panel for rare somatic mutation profiling
  • Grant Resources
Featured Publications
  • MassARRAY helps uncover novel genetic/epigenetic correlation in endometrial cancer
  • Genotyping reveals association between CYP2D6 polymorphisms and tamoxifen outcome
日本語
Copyright © 2005 SEQUENOM, Inc. All Rights Reserved. | Terms & Conditions | Site Map